Skip to Content

G 207 (Moexipril and Hydrochlorothiazide 12.5 mg / 7.5 mg)

Pill imprint G 207 has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg.

Moexipril is used in the treatment of diabetic kidney disease; high blood pressure; heart attack; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg G 207
Discount Card Promo
Hydrochlorothiazide and moexipril hydrochloride
Imprint:
G 207
Strength:
12.5 mg / 7.5 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Glenmark Generics Inc.
National Drug Code (NDC):
68462-0207
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium oxide
magnesium stearate
povidone
hydroxypropyl cellulose (type h)
hypromelloses
polyethylene glycol 6000
titanium dioxide
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide